Cingulate is trading at $4.70, down 5.05% in pre-market, with no clear catalyst identified. - No company announcement dated September 30 or October 1 appears on Cingulate’s press-release page; its latest listed release is from September 17. - Market context was mixed: the Nasdaq was up 0.48%, while the Dow was down 0.48%, offering no broad-market explanation for Cingulate’s decline.